Biotechnology, In Vitro Production of Natural Bioactive Compounds, Herbal Preparation, and Disease Management (Treatment and Prevention)

  • A. N. M. Alamgir
Part of the Progress in Drug Research book series (PDR, volume 74)


Biotechnology uses living systems to develop products and plant biotechnology generates useful products or services, e.g., different bioactive secondary metabolites including alkaloids, flavonoids and other phenolics, saponins, terpenoids, steroids, glycosides, tannins, volatile oils, etc., from plant cells, tissues or organs culture independent of geographical and climatic factors under aseptic conditions. These bioactive compounds are economically important as drugs (pharmaceuticals), flavors, perfumes (fragrances), pigments (dyes), agrochemicals as well as cosmetics, food additives, etc. Different strategies, e.g., genetic transformation of plants with Agrobacterium rhizogenes, hairy roots and others can be applied for the improvement of production of bioactive compounds of secondary metabolic origin. Recombinant DNA techniques can be used to manipulate metabolic pathways and produce protein pharmaceuticals such as antibodies, and protein hormones. Bioinformatics and genomics can find application in drug discovery from plant-based products and biotechnological procedures can enhance and advance the studies of medicinal plants. Molecular biotechnology uses laboratory techniques to study and modify nucleic acids and proteins for applications in areas such as human and animal health, agriculture, and the environment. Herbal extracts are now widely used in the management of chronic diseases like diabetes, hypertension, cancer, etc., as a part of CAM therapy. Plant-derived immune stimulators diverse small or large molecules (saponins, tomatine, inulin, polysaccharides), fungal β-glucans, complex molecules from marine sponge (α-galactosylceramide), shrimp chitin (chitosan), etc., have established adjuvant activity. Immunotherapy may be activation immunotherapy or suppression immunotherapy. Vaccines provide immune protection against diseases and plant-based edible vaccine production mainly involves the integration of transgene into the plant cells to produce the antigen protein for specific disease.


Biotechnology Ascetic culture Disease management Chronic diseases Immunotherapy Edible vaccine 


  1. Alamgir ANM (2017) Therapeutic use of medicinal plants and their extracts: volume 1, Pharmacognosy. In: Rainsford KD (ed) Progress in drug research, vol 73. pp 403–426Google Scholar
  2. Atsmon J, Brill-Almon E, Nadri-Shay C et al (2015) Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R. Toxicol Appl Pharmacol 287(3):202–209CrossRefPubMedGoogle Scholar
  3. Barker LR, Burton JR et al (eds) (1995) Principles of Ambulatory Medicine, 4th edn. Williams & Wilkins, Baltimore, Md, pp 803–843Google Scholar
  4. Bhushan MS, Rao CHV, Ojha SK, Vijayakumar M, Verma A (2010) An analytical review of plants for anti diabetic activity with their phytoconstituent and mechanism of action. IJPSR. 1(1):29–46Google Scholar
  5. Cefalu WT, Stephens JM, Ribnicky DM (2011) Diabetes and herbal (botanical) medicine, Chapter 19. In: Benzie IFF, Wachtel-Galor S (eds) Herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press/Taylor & Francis, Boca Raton (FL)Google Scholar
  6. Cragg GM, Newman DJ (2005) Plants as a source of anti-cancer agents. J Ethnopharmacol 100:72–79CrossRefPubMedGoogle Scholar
  7. Gavras H (2009) Pathogenesis of hypertension: a review. J Med Sci 2(1):25–28Google Scholar
  8. Ghosh PK (1995) Role of biotechnology in health care in India: present and future. Biotech Dev Rev, pp 1–22. (June–Dec 1995)Google Scholar
  9. Greer AL (2015) Early vaccine availability represents an important public health advance for the control of pandemic influenza. BMC Res Notes 8(1):191CrossRefPubMedPubMedCentralGoogle Scholar
  10. Kapoor R, Sharma B, Kanwar SS (2017) Antiviral phytochemicals: an overview. Biochem Physiol 6:220. Scholar
  11. Karuppusamy S (2009) A review on trends in production of secondary metabolites from higher plants by in vitro tissue, organ and cell cultures. J Med Plants Res 3(13):1222–1239Google Scholar
  12. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223CrossRefPubMedGoogle Scholar
  13. Kim MY, Yang MS, Kim TG (2009) Expression of dengue virus e glycoprotein domain III in non-nicotine transgenic tobacco plants. Biotechnol Bioprocess Eng 14(6):725–730CrossRefGoogle Scholar
  14. Lai H, Chen Q (2012) Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Rep 31(3):573–584CrossRefPubMedGoogle Scholar
  15. Li T, Sun JK, Lu ZH, Liu Q (2011) Transformation of HBsAg (hepatitis B surface antigen) gene into tomato mediated by Agrobacterium tumefaciens. Czech J Genet Plant Breed 47(2):69–77CrossRefGoogle Scholar
  16. Lifton R (1996) Molecular genetics of human blood pressure variation. Science 272(5262):676–680CrossRefPubMedGoogle Scholar
  17. Lin LT, Hsu WC, Lin CC (2014) Antiviral natural products and herbal medicines. J Tradit Complement Med 4(1):24–35CrossRefPubMedPubMedCentralGoogle Scholar
  18. Malabadi RB, Meti NT, Mulgund GS, Nataraja K, Kumar SV (2012) Recent advances in plant derived vaccine antigens against human infectious diseases. Res Pharm 2(2):8–19Google Scholar
  19. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM et al (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314(5796):126–129CrossRefPubMedPubMedCentralGoogle Scholar
  20. Penney CA, Thomas DR, Deen SS, Walmsley AM (2011) Plant-made vaccines in support of the millennium development goals. Plant Cell Rep 30(5):789–798CrossRefPubMedPubMedCentralGoogle Scholar
  21. Perea Arango I, Loza Rubio E, Rojas Anaya E, Olivera Flores T, de la Vara LG, Lim GMA (2008) Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice. Plant Cell Rep 27(4):677–685CrossRefPubMedGoogle Scholar
  22. Phoolcharoen W, Bhoo SH, Lai H et al (2011) Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. Plant Biotechnol J 9(7):807–816CrossRefPubMedGoogle Scholar
  23. Ren-Ren BAI, Xiao-Ming WU, Jin-Yi XU (2015) Reviews: current natural products with antihypertensive activity. Chinese J Natural Medicines 13(10):0721–0729CrossRefGoogle Scholar
  24. Rigano MM, Alvarez ML, Pinkhasov J et al (2004) Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. Plant Cell Rep 22(7):502–508CrossRefPubMedGoogle Scholar
  25. Sofowora A, Ogunbodede E, Onayade A (2013) The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med 10(5):210–229PubMedPubMedCentralGoogle Scholar
  26. Strasser R, Castilho A, Stadlmann J et al (2009) Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous β1, 4-galactosylated N-glycan profile. J Biol Chem 284(31):20479–20485CrossRefPubMedPubMedCentralGoogle Scholar
  27. Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S (2004) Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22(31–32):4385–4389CrossRefPubMedGoogle Scholar
  28. Thuenemann EC, Meyers AE, Verwey J, Rybicki EP, Lomonossoff GP (2013) A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J 11(7):839–846CrossRefPubMedGoogle Scholar
  29. Tulunay M, Aypak C, Yikilkan H, Gorpelioglu S (2015) Herbal medicine use among patients with chronic diseases. J Intercult Ethnopharmacol 4(3):217–220CrossRefPubMedPubMedCentralGoogle Scholar
  30. Wang DM, Zhu JB, Peng M, Zhou P (2008) Induction of a protective antibody response to FMDV in mice following oral immunization with transgenic Stylosanthes spp. as a feedstuff additive. Transgenic Res 17(6):1163–1170CrossRefPubMedGoogle Scholar
  31. Woods N, Niwasabutra K, Acevedo R, Igoli J, Altwaijry NA Tusiimire J et al (2017) Natural vaccine adjuvants and immunopotentiators derived from plants, fungi, marine organisms, and insects, Chapter 11. In: Schijns VEJC, O’Hagan DT (eds) Immunopotentiators in modern vaccines, 2nd edn. Academic Press, Copyright © 2017 Elsevier Ltd., pp 211–229CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of BotanyChittagong UniversityChittagongBangladesh

Personalised recommendations